The ORC1 Gene Meier-Gorlin Syndrome Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ORC1 gene, which are linked to Meier-Gorlin Syndrome Type 1. This rare genetic disorder is characterized by growth delays before and after birth, small ears, and, in many cases, absent or underdeveloped kneecaps. The test plays a crucial role in the early diagnosis and management of the syndrome, allowing for tailored care and interventions to improve the quality of life for affected individuals. Priced at 4400 AED, the test involves analyzing the patient's DNA to detect any abnormalities in the ORC1 gene, providing a definitive diagnosis for families seeking answers to their medical concerns. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test is a vital resource for individuals and families affected by Meier-Gorlin Syndrome Type 1, offering hope and guidance through precise genetic insights.
The ORC4 Gene Meier-Gorlin Syndrome Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ORC4 gene, which are associated with Meier-Gorlin Syndrome Type 2 (MGORS2). Meier-Gorlin Syndrome is a rare genetic disorder characterized by short stature, small ears, and, in some cases, skeletal abnormalities. The ORC4 gene plays a critical role in DNA replication, and mutations in this gene can lead to the developmental issues observed in MGORS2.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the ORC4 gene. This genetic testing is crucial for accurate diagnosis, allowing for tailored treatment and management plans for affected individuals. It also provides essential information for family planning and genetic counseling for families with a history of the condition.
The cost of the ORC4 Gene Meier-Gorlin Syndrome Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, including the expertise required to accurately identify and interpret mutations in the ORC4 gene. Families and individuals considering this test are encouraged to discuss it with their healthcare provider to understand its benefits and implications fully.
The GDF6 Gene Klippel-Feil Syndrome Type 1 Autosomal Dominant Genetic Test is a specialized diagnostic examination offered at DNA Labs UAE, aimed at identifying mutations in the GDF6 gene which are associated with Klippel-Feil Syndrome Type 1. Klippel-Feil Syndrome is a rare congenital condition characterized by the fusion of two or more cervical vertebrae, leading to a variety of symptoms including a limited range of neck motion, short neck, and low hairline at the back of the head. As an autosomal dominant condition, having a mutation in just one of the two copies of the GDF6 gene is sufficient to cause the syndrome.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect the presence of genetic mutations in the GDF6 gene. This genetic testing is crucial for accurate diagnosis, guiding treatment decisions, and providing information on the risk of passing the condition to future generations. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and comprehensive diagnostic services, this test represents a critical step for individuals suspected of having Klippel-Feil Syndrome Type 1 or those with a family history of the condition, seeking to understand their genetic health.
The MEOX1 Gene Klippel-Feil Syndrome Type 2 Autosomal Dominant Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the MEOX1 gene, which are associated with Klippel-Feil Syndrome Type 2 (KFS2). KFS2 is a rare genetic disorder characterized by the congenital fusion of any two of the seven cervical vertebrae. It is part of a broader spectrum of disorders affecting spinal segmentation and alignment, leading to a range of symptoms from mild neck stiffness to more severe neurological complications due to spinal cord or nerve root involvement.
The test is aimed at individuals who exhibit symptoms of KFS2 or have a family history of the condition, offering them a precise genetic diagnosis. By confirming the presence of a mutation in the MEOX1 gene, the test can help in the development of a tailored management plan for the affected individual. It is also valuable for families seeking information on the risk of passing the condition to future generations, given its autosomal dominant inheritance pattern. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy and reliability, providing essential genetic insights for affected individuals and their families.
The GDF3 gene is associated with Klippel-Feil Syndrome Type 3, a condition characterized by the congenital fusion of any two of the seven cervical vertebrae. It is a form of skeletal anomaly that leads to a limited range of motion in the neck and can be accompanied by other developmental issues in the body. The condition is inherited in an autosomal dominant pattern, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder.
To diagnose this specific subtype of Klippel-Feil Syndrome, genetic testing focusing on the GDF3 gene is essential. This test can confirm the presence of mutations in the GDF3 gene that are known to cause the syndrome. Conducting this test is crucial for accurate diagnosis, informed decision-making regarding treatment options, and understanding the risk of passing the condition on to future generations.
In the UAE, DNA Labs offers this specialized genetic test for Klippel-Feil Syndrome Type 3. The test cost is set at 4400 AED. DNA Labs UAE is equipped with advanced genetic testing technologies and staffed by professionals skilled in conducting and interpreting these tests. Opting for this test at DNA Labs UAE ensures a comprehensive analysis of the GDF3 gene to ascertain the genetic basis of the condition in affected individuals or families with a history of Klippel-Feil Syndrome.
The MYO18B gene is associated with a rare genetic disorder known as Klippel-Feil Syndrome Type 4, which is characterized by the congenital fusion of any two of the seven cervical vertebrae. It is an autosomal dominant condition, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder. This particular type of Klippel-Feil Syndrome is unique because it is also associated with myopathy, a muscle disorder that affects muscle tone or strength, and facial dysmorphism, which refers to a group of facial abnormalities that occur together in a recognizable pattern.
To diagnose this complex condition, genetic testing is available at DNA Labs UAE, which can confirm the presence of mutations in the MYO18B gene. The test is crucial for individuals who exhibit symptoms of Klippel-Feil Syndrome Type 4, as it can provide definitive confirmation of the diagnosis. This information can be invaluable for affected individuals and their families in terms of understanding the condition, its inheritance pattern, and making informed decisions about management and care.
The cost of the genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect mutations in the MYO18B gene. Given the complexity of the condition and the importance of accurate diagnosis, the test is a critical step for individuals presenting with symptoms consistent with Klippel-Feil Syndrome Type 4, as well as for their family members who may be at risk.
The COL2A1 gene Kniest Dysplasia genetic test is a specific diagnostic tool designed to identify mutations in the COL2A1 gene, which are responsible for Kniest Dysplasia, a rare type of skeletal dysplasia characterized by short stature, enlarged joints, and other skeletal abnormalities. This condition is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder.
Conducted at DNA Labs UAE, this test is crucial for the accurate diagnosis of Kniest Dysplasia, enabling healthcare providers to offer appropriate management and treatment plans for affected individuals. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific mutations in the COL2A1 gene that are known to cause the condition.
The cost of the COL2A1 gene Kniest Dysplasia genetic test at DNA Labs UAE is 4400 AED. This price may cover the test procedure, analysis, and the provision of a detailed report by the lab's genetic counselors or specialists, who will explain the results and their implications for the patient and their family. Given the complexity and rarity of Kniest Dysplasia, accessing this specialized genetic testing can be a crucial step in obtaining a definitive diagnosis and facilitating targeted interventions to manage symptoms and improve quality of life.
The KANSL1 Gene Koolen Syndrome Genetic Test is a specialized diagnostic tool designed to detect mutations in the KANSL1 gene, which are associated with Koolen-de Vries syndrome. This condition is characterized by a range of symptoms including developmental delay, intellectual disability, distinctive facial features, and in some cases, seizures and heart defects. The test is crucial for confirming a diagnosis of Koolen-de Vries syndrome, allowing for appropriate management and care plans to be established.
Performed at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities, this test offers a reliable means of analysis for individuals suspected of having Koolen-de Vries syndrome. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the KANSL1 gene. By opting for this test, patients and their families can gain valuable insights into their genetic condition, facilitating informed decisions regarding treatment and support.
The FGF10 gene plays a crucial role in the development of various tissues, including those in the limbs, ears, and salivary glands. Mutations in the FGF10 gene can lead to Lacrimo-Auriculo-Dento-Digital (LADD) Syndrome, a rare genetic disorder characterized by abnormalities in tear ducts, ears, teeth, and digits. Early and accurate diagnosis is crucial for managing the symptoms and improving the quality of life for those affected.
DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the FGF10 gene associated with LADD Syndrome. This test is an essential tool for families seeking answers about this condition, enabling healthcare providers to devise appropriate management and treatment plans based on the genetic information.
The cost of the FGF10 Gene LADD Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the specific genetic alterations within the FGF10 gene that could be responsible for the manifestation of LADD Syndrome. By opting for this test, individuals gain valuable insights into their genetic makeup, paving the way for personalized medical care and informed decision-making regarding their health and that of their family members.
The FGFR2 Gene LADD Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the FGFR2 gene, which are associated with Lacrimo-Auriculo-Dento-Digital (LADD) Syndrome. LADD Syndrome is a rare genetic disorder characterized by abnormalities in tear ducts, ears, teeth, and fingers. The test is crucial for individuals showing symptoms of LADD Syndrome or those with a family history of the condition, as it can provide definitive genetic evidence of the disorder.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed to detect any genetic alterations in the FGFR2 gene that could indicate the presence of LADD Syndrome. This genetic test is an important step in the diagnosis and management of the condition, enabling targeted treatment and interventions to improve the quality of life for affected individuals.
The cost of the FGFR2 Gene LADD Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full process of genetic analysis and a comprehensive report of the findings. Given the specialized nature of this test and its potential to significantly impact patient care, it represents a valuable investment in personal health and well-being for those at risk of LADD Syndrome.
